Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis
Clinical trial NCT01384630 · COMPLETED
Trial details
- NCT number
- NCT01384630
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-30
- Primary completion
- 2012-07-31
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.